Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995

Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995–2015

Published:2019-11-30 Issue:2 Volume:22 Page:301-302
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Davis Faith G¹²,Smith Trenton R¹²,Gittleman Haley R³^ORCID,Ostrom Quinn T³⁴,Kruchko Carol³,Barnholtz-Sloan Jill S³⁵^ORCID

Affiliation:

1. Brain Tumour Registry of Canada, London, Ontario, Canada

2. School of Public Health, University of Alberta, Edmonton, Alberta, Canada

3. Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA

4. Department of Medicine, Epidemiology, and Population Sciences, Dan L Duncan Comprehensive Cancer Center, Houston, Texas, USA

5. Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio, USA

Funder

Brain Canada Foundation

Musella Foundation

National Brain Tumor Society

Children’s Brain Tumor Foundation

Zelda Dorin Tetenbaum Memorial Fund

Uncle Kory Foundation

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noz203/31177197/noz203.pdf

Reference6 articles.

1. Brain tumours: rise in glioblastoma multiforme incidence in England 1995-2015 suggests an adverse environmental or lifestyle factor;Philips;J Environ Public Health.,2018

2. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016

3. Current status of brain tumor surveillance in Canada and why it matters;Davis;J Registry Manag.,2015

4. The impact of hospital discharge linkage on case ascertainment of brain tumours in the Alberta Cancer Registry, 2010–2015;Eckstrand;J Registry Manag.,2018

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian population;Journal of Neuro-Oncology;2024-08-27

2. Temozolomide based treatment in glioblastoma: 6 vs. 12 months;Oncology Letters;2024-07-02

3. Glioblastoma: A molecular insight into current discoveries and treatment directions;Medical Journal of Cell Biology;2024-07-01

4. The role of lactate-induced protein lactylation in gliomas: implications for preclinical research and the development of new treatments;Frontiers in Pharmacology;2024-06-25

5. Impact of clinical target volume margin reduction in glioblastoma patients treated with concurrent chemoradiation;Neuro-Oncology Practice;2023-10-27